SuperSonic Imagine: Strong Revenue Growth in 1H 2014: +34% to €9.2 million

Regulatory News:

SuperSonic Imagine (Paris:SSI) (Euronext: SSI, FR0010526814, PEA-PME eligible), a company specialized in ultrasound medical imaging, today announces its first half and second quarter revenue for the period ending June 30, 2014.

SuperSonic Imagine’s revenue for the first half of 2014 totaled €9.2m, up +34% on June 30, 2013.

In the second quarter, the Group recorded sales growth of +21%. Over the quarter, SuperSonic Imagine maintained a strong sales growth dynamic in Asia, which represented the largest zone in terms of revenue, with the Americas and EMEA zones each accounting for less than a third of sales.

Over the first half, the Group recorded a +19% increase in Product sales to €7.4m (compared to €6.2m in 1H 2013). At constant exchange rates, this growth would have been +20%. The proportion of Product sales remained stable, accounting for 91% of total sales, versus 9% for Services. EMEA accounted for nearly half of all 1H activity on the back of a very strong first quarter for this region. Asia continued to record strong growth (+48% year on year) and the Americas zone also recorded solid growth.

Other revenue is essentially derived from technology access fees. This revenue is not counted as sales insofar as it is not part of SuperSonic Imagine’s core business and it will not occur regularly.

Gordon Waldron, Executive Vice-President and CFO of SuperSonic Imagine, says: "We are pleased with the momentum recorded over the second quarter which supports our development strategy and shows solid Aixplorer^® penetration in our priority markets”.

Jacques Souquet, Founder and CEO of SuperSonic Imagine, concludes: "The good performance achieved this quarter ends a particularly fruitful first half of 2014 for SuperSonic Imagine, notably with the success of our IPO in April. We have recorded a solid half-year performance with total revenue growth of more than +30%”.

Next press release: half-year financial results on September 3, 2014

About SuperSonic Imagine
Founded in 2005 and based in Aix-en-Provence (France), SuperSonic Imagine is a company specializing in medical imaging. The company designs, develops and markets a revolutionary ultrasound system, Aixplorer^®, with an UltraFast™ platform that can acquire images 200 times faster than conventional ultrasound systems. Aixplorer^® is the only system that can image two types of waves: ultrasound waves ensure excellent image quality and shear waves, which allow physicians to visualize and analyze the stiffness of tissue in a real-time, reliable, reproducible and non-invasive manner. This innovation, ShearWave™ Elastography, significantly improves the detection and characterization of numerous pathologies in several applications including breast, thyroid, liver and prostate. SuperSonic Imagine has been granted regulatory clearances for the commercialization of Aixplorer^® in the main global markets. Over the past years, SuperSonic Imagine enjoyed the backing of several prestigious investors, among which Auriga Partners, Edmond de Rothschild Investment Partners, Bpifrance, Omnes Capital and NBGI.

For more information about SuperSonic Imagine, please go to www.supersonicimagine.com